Financial statements Nowa Pharm W Likwidacji
Balance sheet data of NOWA PHARM W LIKWIDACJI
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|
| Total assets | 51 933 536,22 | 45 313 928,94 | 44 859 067,08 | 57 096 412,09 | 3 946 247,39 | 63 676,80 |
| A. Fixed assets | 22 302 894,87 | 22 285 937,14 | 22 276 163,88 | 42 198 437,25 | 179 226,28 | 0,00 |
| B. Current assets | 29 630 641,35 | 23 027 991,80 | 22 582 903,20 | 14 897 974,84 | 3 767 021,11 | 63 676,80 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - | 0,00 |
| Total liabilities | 51 933 536,22 | 45 313 928,94 | 44 859 067,08 | 57 096 412,09 | 3 946 247,39 | 63 676,80 |
| A. Equity | -11 806 668,64 | -19 564 042,30 | -21 841 127,20 | -25 849 063,55 | -43 457 786,30 | -44 265 970,27 |
| B. Liabilities and provisions for liabilities | 63 740 204,86 | 64 877 971,24 | 66 700 194,28 | 82 945 475,64 | 47 404 033,69 | 44 329 647,07 |
| I. Long-term liabilities | 10 952 862,00 | 63 057 374,06 | 8 181 693,88 | 70 439 296,15 | 0,00 | 0,00 |
| II. Short-term liabilities | 52 761 543,24 | 1 802 636,51 | 58 514 950,13 | 12 505 069,25 | 47 229 235,41 | 44 302 668,54 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.